kharkiv ukraine january 2021 syringe two vials doses coronavirus vaccine with sinovac logo blue background the

navigate by keyword : banner biontech blue bottle china company concept copy corona coronavirus covid cure disease dose drug epidemic experimental global health illness immune immunization injection lab laboratory medical medicine mutation ncov needle new pandemic pfizer pharmacy pneumonia prevention protection research sarscov science sinovac space strain syringe test vaccination vaccine vial virus

Kharkiv. Ukraine. January 9, 2021. Syringe, threevials of coronavirus vaccine with Sinovac logo on a blue background.The concept Royalty Free Stock Photo
Kharkiv. Ukraine. January 9, 2021.Syringe, two vials two doses of coronavirus vaccine with Sinovac logo a blue background.The Royalty Free Stock Photo
Kharkiv. Ukraine. January 9, 2021. Syringe, two vials two doses of coronavirus vaccine with Sinovac logo a blue background.The Royalty Free Stock Photo
Kharkiv. Ukraine. January 9, 2021. Syringe, two vials of coronavirus vaccine with Sinovac logo on a blue background.The concept of Royalty Free Stock Photo
Kharkiv. Ukraine. January 9, 2021. Syringe, two vials of coronavirus vaccine with Sinovac logo on a blue background.The concept of Royalty Free Stock Photo
   
   
Kharkiv. Ukraine. January 9, 2021.Syringe, two vials two doses of coronavirus vaccine with Sinovac logo a blue background.The
Kharkiv. Ukraine. January 9, 2021. Syringe, two vials of coronavirus vaccine with Sinovac logo on a blue background.The concept of Royalty Free Stock Photo
Kharkiv. Ukraine. January 9, 2021. Syringe, three vials of coronavirus vaccine with Sinovac logo on a blue background.The concept Royalty Free Stock Photo
   
   
   
   
   
Kharkiv. Ukraine. January 9, 2021.Syringe, two vials two doses of coronavirus vaccine with Sinovac logo a blue background.The concept of medicine, healthcare and science.Copy space for text.Banner


Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.